Hsd:WI |
plasma creatinine level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
0 days
| 8 |
1.67 |
mg/dl |
0.12 |
0.33 |
liquid phase colorimetry |
0.0 |
0 |
75946 |
1542 |
Hsd:WI |
plasma uric acid level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
0 days
| 8 |
4.89 |
mg/dl |
0.35 |
0.98 |
liquid phase colorimetry |
0.0 |
0 |
75950 |
1542 |
Hsd:WI |
plasma urea nitrogen level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
0 days
| 8 |
8.05 |
mmol/l |
0.44 |
1.25 |
liquid phase colorimetry |
0.0 |
0 |
75940 |
1542 |
Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
0 days
| 8 |
46.14 |
null |
1.7 |
4.82 |
liquid phase colorimetry |
0.0 |
0 |
76216 |
1542 |
Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
1.93 |
null |
0.07 |
0.2 |
liquid phase colorimetry |
0.0 |
0 |
76218 |
1542 |
Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
2.92 |
null |
0.11 |
0.32 |
liquid phase colorimetry |
0.0 |
0 |
76220 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
242.2 |
U/mg |
5.3 |
15.0 |
liquid phase colorimetry |
0.0 |
0 |
76200 |
1542 |
Hsd:WI |
kidney glutathione level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
0 days
| 8 |
126.5 |
ug/g |
1.5 |
4.23 |
liquid phase colorimetry |
0.0 |
0 |
76230 |
1542 |
Hsd:WI |
kidney glutathione level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
0 days
| 8 |
108.4 |
ug/g |
4.56 |
12.9 |
liquid phase colorimetry |
0.0 |
0 |
76232 |
1542 |
Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
292.4 |
U/mg |
14.25 |
40.3 |
liquid phase colorimetry |
0.0 |
0 |
76202 |
1542 |
Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
19.72 |
null |
0.82 |
2.31 |
liquid phase colorimetry |
0.0 |
0 |
76228 |
1542 |
Hsd:WI |
plasma uric acid level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
0 days
| 8 |
2.79 |
mg/dl |
0.18 |
0.52 |
liquid phase colorimetry |
0.0 |
0 |
75948 |
1542 |
Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
8.49 |
null |
0.4 |
1.14 |
liquid phase colorimetry |
0.0 |
0 |
76222 |
1542 |
Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
18.63 |
null |
0.61 |
1.73 |
liquid phase colorimetry |
0.0 |
0 |
76224 |
1542 |
Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
0 days
| 8 |
54.88 |
null |
1.74 |
4.93 |
liquid phase colorimetry |
0.0 |
0 |
76214 |
1542 |
Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
0 days
| 8 |
12.45 |
null |
0.43 |
1.23 |
liquid phase colorimetry |
0.0 |
0 |
76226 |
1542 |
Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
0 days
| 8 |
14.83 |
U/mg |
0.43 |
1.21 |
liquid phase colorimetry |
0.0 |
0 |
76212 |
1542 |
Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
0 days
| 8 |
19.45 |
U/mg |
0.75 |
2.13 |
liquid phase colorimetry |
0.0 |
0 |
76210 |
1542 |
Hsd:WI |
plasma urea nitrogen level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
0 days
| 8 |
14.48 |
mmol/l |
0.88 |
2.49 |
liquid phase colorimetry |
0.0 |
0 |
75942 |
1542 |
Hsd:WI |
plasma creatinine level |
benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
0 days
| 8 |
0.27 |
mg/dl |
0.02 |
0.05 |
liquid phase colorimetry |
0.0 |
0 |
75944 |
1542 |